In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-18 of 18 for your search:
Drug:  cilengitide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMD 121974-011, EORTC 26071-22072, NCT00689221
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-9911, JHOC-NABTT-9911, NCT00006093
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02932, NABTT 0306, CDR0000368451, U01CA062475, ABTC-0306, NCT00085254
4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 200052-013, 2008-000615-15, NCT00705016
5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR 200037-014, EudraCT Number: 2008-004148-35, NCT00842712
6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-0408014-01, EMD-121974-009, MERCK-EMD-121974-009, NCT0093964
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02653, NABTC-0302, U01CA062399, CDR0000428409, NCT00112866
8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03066, 2004-045, N01CM62206, CDR0000438708, CCUM-2004-045, 6735, NCI-6735, NCT00121238
9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: H2007-0087, CO05601, NCT00590824
10.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2009-00339, ACNS0621, U10CA098543, CDR0000595623, COG-ACNS0621, NCT00679354
11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMD 121974-012, NCT00813943
12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02904, UMCC 2004.030, N01CM62202, CCUM-2004-030, NCI-6372, 6372, UCSF-045512, UCSF-H45860-26715-01B, NCT00103337
13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02392, 00-1096, U01CA099176, CDR0000068786, UCHSC-001096, NCI-3358, 3358, NCT00022113
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02569, UCCRC-12774A, CDR0000349535, NCI-6362, 6362, NCT00077155
15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 9909-40; T99-0076, IUMC-9909-40, NCI-T99-0076, T99-0076, NCT00004258
16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-03175, PBTC-012, U01CA081457, CDR0000305859, NCT00063973
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02919, 0903, CDR0000654715, U01CA137443, ABTC-0903, NCT00979862
18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01455, 09-259-A, CDR0000659080, UCCRC-09-259-A, U01CA069852, 8313, NCT01122888
New Search